Cargando…
A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease
BACKGROUND: Genetic programming (GP) is an evolutionary computing methodology capable of identifying complex, non-linear patterns in large data sets. Despite the potential advantages of GP over more typical, frequentist statistical approach methods, its applications to survival analyses are rare, at...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122798/ https://www.ncbi.nlm.nih.gov/pubmed/30180175 http://dx.doi.org/10.1371/journal.pone.0202685 |
_version_ | 1783352729672876032 |
---|---|
author | Bannister, Christian A. Halcox, Julian P. Currie, Craig J. Preece, Alun Spasić, Irena |
author_facet | Bannister, Christian A. Halcox, Julian P. Currie, Craig J. Preece, Alun Spasić, Irena |
author_sort | Bannister, Christian A. |
collection | PubMed |
description | BACKGROUND: Genetic programming (GP) is an evolutionary computing methodology capable of identifying complex, non-linear patterns in large data sets. Despite the potential advantages of GP over more typical, frequentist statistical approach methods, its applications to survival analyses are rare, at best. The aim of this study was to determine the utility of GP for the automatic development of clinical prediction models. METHODS: We compared GP against the commonly used Cox regression technique in terms of the development and performance of a cardiovascular risk score using data from the SMART study, a prospective cohort study of patients with symptomatic cardiovascular disease. The composite endpoint was cardiovascular death, non-fatal stroke, and myocardial infarction. A total of 3,873 patients aged 19–82 years were enrolled in the study 1996–2006. The cohort was split 70:30 into derivation and validation sets. The derivation set was used for development of both GP and Cox regression models. These models were then used to predict the discrete hazards at t = 1, 3, and 5 years. The predictive ability of both models was evaluated in terms of their risk discrimination and calibration using the validation set. RESULTS: The discrimination of both models was comparable. At time points t = 1, 3, and 5 years the C-index was 0.59, 0.69, 0.64 and 0.66, 0.70, 0.70 for the GP and Cox regression models respectively. At the same time points, the calibration of both models, which was assessed using calibration plots and the generalization of the Hosmer-Lemeshow test statistic, was also comparable, but with the Cox model being better calibrated to the validation data. CONCLUSION: Using empirical data, we demonstrated that a prediction model developed automatically by GP has predictive ability comparable to that of manually tuned Cox regression. The GP model was more complex, but it was developed in a fully automated way and comprised fewer covariates. Furthermore, it did not require the expertise normally needed for its derivation, thereby alleviating the knowledge elicitation bottleneck. Overall, GP demonstrated considerable potential as a method for the automated development of clinical prediction models for diagnostic and prognostic purposes. |
format | Online Article Text |
id | pubmed-6122798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61227982018-09-16 A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease Bannister, Christian A. Halcox, Julian P. Currie, Craig J. Preece, Alun Spasić, Irena PLoS One Research Article BACKGROUND: Genetic programming (GP) is an evolutionary computing methodology capable of identifying complex, non-linear patterns in large data sets. Despite the potential advantages of GP over more typical, frequentist statistical approach methods, its applications to survival analyses are rare, at best. The aim of this study was to determine the utility of GP for the automatic development of clinical prediction models. METHODS: We compared GP against the commonly used Cox regression technique in terms of the development and performance of a cardiovascular risk score using data from the SMART study, a prospective cohort study of patients with symptomatic cardiovascular disease. The composite endpoint was cardiovascular death, non-fatal stroke, and myocardial infarction. A total of 3,873 patients aged 19–82 years were enrolled in the study 1996–2006. The cohort was split 70:30 into derivation and validation sets. The derivation set was used for development of both GP and Cox regression models. These models were then used to predict the discrete hazards at t = 1, 3, and 5 years. The predictive ability of both models was evaluated in terms of their risk discrimination and calibration using the validation set. RESULTS: The discrimination of both models was comparable. At time points t = 1, 3, and 5 years the C-index was 0.59, 0.69, 0.64 and 0.66, 0.70, 0.70 for the GP and Cox regression models respectively. At the same time points, the calibration of both models, which was assessed using calibration plots and the generalization of the Hosmer-Lemeshow test statistic, was also comparable, but with the Cox model being better calibrated to the validation data. CONCLUSION: Using empirical data, we demonstrated that a prediction model developed automatically by GP has predictive ability comparable to that of manually tuned Cox regression. The GP model was more complex, but it was developed in a fully automated way and comprised fewer covariates. Furthermore, it did not require the expertise normally needed for its derivation, thereby alleviating the knowledge elicitation bottleneck. Overall, GP demonstrated considerable potential as a method for the automated development of clinical prediction models for diagnostic and prognostic purposes. Public Library of Science 2018-09-04 /pmc/articles/PMC6122798/ /pubmed/30180175 http://dx.doi.org/10.1371/journal.pone.0202685 Text en © 2018 Bannister et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Bannister, Christian A. Halcox, Julian P. Currie, Craig J. Preece, Alun Spasić, Irena A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title | A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title_full | A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title_fullStr | A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title_full_unstemmed | A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title_short | A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular disease |
title_sort | genetic programming approach to development of clinical prediction models: a case study in symptomatic cardiovascular disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122798/ https://www.ncbi.nlm.nih.gov/pubmed/30180175 http://dx.doi.org/10.1371/journal.pone.0202685 |
work_keys_str_mv | AT bannisterchristiana ageneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT halcoxjulianp ageneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT curriecraigj ageneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT preecealun ageneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT spasicirena ageneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT bannisterchristiana geneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT halcoxjulianp geneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT curriecraigj geneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT preecealun geneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease AT spasicirena geneticprogrammingapproachtodevelopmentofclinicalpredictionmodelsacasestudyinsymptomaticcardiovasculardisease |